James J Harding, Associate Member of Gastrointestinal Oncology and Early Drug Development Service at Memorial Sloan Kettering Cancer Center, shared a post on LinkedIn:
“Great work Orla M. Fitzpatrick!
Glad you are part of our HPB team at Memorial Sloan Kettering Cancer Center.
Excellent editorial on HER2 directed therapy in patients with biliary tract cancer.
Thank you, AACR Journals, for publishing a head of print on World Cholangiocarcinoma Day!”
Title: Shaping the future of HER2-directed therapy in biliary tract cancer
Authors: Orla M. Fitzpatrick, James J. Harding
Read the full article here.
Other OncoDaily articles featuring James J Harding.